Synairgen
+GBX0.37+10.42% Friday 15:29
This list is based on the watchlists of people on Stock Events who follow SNG.LSE. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Show more...